anti-doping is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Fragment analog of human growth hormone |
| Sequence basis | hGH 176–191 region | Modified C-terminal fragment |
| Common synonyms | AOD-9604; AOD9604; hGH fragment | Research and trade names vary |
| Regulatory status | Not approved as a drug | Prohibited in competitive sport |
| Research code | AOD9604 | Used in scientific and patent literature |
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Opium was prohibited in many countries during the early 20th century, leading to the modern pattern of opium production as a precursor for illegal recreational drugs or tightly regulated, highly taxed, legal prescription drugs. In 1980, 2,000 tons of opium supplied all legal and illegal uses. Worldwide production in 2006 was 6610 tonnes—about one-fifth the level of production in 1906; since then, opium production has fallen. In 2002, the price for one kilogram of opium was US$300 for the farmer, US$800 for purchasers in Afghanistan, and US$16,000 on the streets of Europe before conversion into heroin. Opium production increased considerably, surpassing 5,000 tons in 2002 and reaching 8,600 tons in Afghanistan and 840 tons in the Golden Triangle in 2014. The World Health Organization has estimated that current production of opium would need to increase fivefold to account for total global medical need. Solar energy panels in use in Afghanistan have allowed farmers to dig their wells deeper, leading to a bumper crop of opium year after year. In a 2023 report, poppy cultivation in southern Afghanistan was reduced by over 80% as a result of Taliban campaigns to stop its use toward opium. This included a 99% reduction of opium growth in the Helmand Province. In November 2023, a U.N report showed that in the entirety of Afghanistan, poppy cultivation dropped by over 95%, removing it from its place as being the world's largest opium producer.
== Release == The first two episodes were released on the Angel streaming platform alongside the theatrical debut of the film. After the rest of season 1 was completed, episode 3 was released on November 26, 2025, with weekly releases thereafter concluding with the season finale on December 25, 2025. As of November 2025, prior to the release of the remainder of season 1, the Homestead film and series had been watched on the Angel app for more than 81 million minutes, and Angel Studios said over a quarter million people had subscribed to the platform to watch the show.
=== Family === In 1987, while in high school, Morgan married his girlfriend Sabina. The pair have three sons together. Morgan filed for divorce in August 2009, after having been separated for approximately eight years. Morgan credits one of his sons with having saved him from his alcoholism. Of his extended family, Morgan said in 2009, "I'm estranged from my own mother and most of my family, and I'm not sure that's going to change much". Morgan then dated Tanisha Hall. She donated one of her kidneys to Morgan in December 2010. In September 2011, on the red carpet at the Emmy Awards, Morgan announced he and model Megan Wollover had become engaged six months earlier in San Francisco. Their first child, a daughter, was born in New York City on July 2, 2013. Morgan and Wollover married on August 23, 2015. Morgan filed for divorce July 2020. In 2023, on an episode of Finding Your Roots, Morgan discovered he is third cousins with American rapper Nas. Morgan joked that working with Daniel Radcliffe on The Fall and Rise of Reggie Dinkins made him "a cool Dad".
Sources: en.wikipedia.org
== Contraindications == Ioxaglic acid is contraindicated in people with hyperthyreosis because of the drug's iodine content. It must not be used for myelography (spinal cord imaging), for hysterosalpingography in women who are pregnant or have an acute inflammation in the pelvic region, or for arthrography if the joint is infected.
=== Pharmacodynamics === Bremelanotide is a non-selective agonist of the melanocortin receptors, MC1 through MC5 (with the exception of MC2, the receptor of ACTHTooltip adrenocorticotropic hormone), but acting primarily as an MC3 and MC4 receptor agonist.
== History == The areas later known as the Sudetenland never formed a single historical region, which makes it difficult to distinguish the history of the Sudetenland separately from that of Bohemia until the advent of nationalism in the 19th century.
The town of Billericay was established in the 13th century in the Manor and Parish of Great Burstead. The Manor of Burgestede is first recorded in an Anglo-Saxon will of 975 AD. In the Domesday Book of 1086, two separate manors are recorded as Burghestada. The name Great Burstead is first recorded in the early 13th century, but the division into Great and Little Burstead Manors had happened by the time of the Norman Conquest. The town of Billericay, first recorded as Byllyrica in 1291, is understood to have been founded in the 13th century by the Abbot of West Ham, head of the Cistercian community of Stratford Langthorne Abbey, 20 miles (32.2 km) away on the Lower Lea, in what is now inner London. The Abbey held the Manor of Great Burstead at the time. The town was established at the High Street. Like the abandoned Roman settlement just to the south, it benefitted from a prominent position on the high ground forming the watershed on the catchment areas of the rivers Crouch and Wid. It was also on the crossroads (at Sun Corner) of the road from the Thames to Chelmsford (the modern B1007) and the A129 road linking Hutton to Wickford; it is believed that the Crouch may have been navigable as far as Wickford at that time. At this time, the parish church for Billericay was at St Mary Magdalene, Great Burstead. By the 14th century, a chantry chapel had been built on the High Street, which became a chapel of ease to Great Burstead following the Reformation; it eventually became a parish church in 1844, also dedicated to St Mary Magdalen.
Sources: en.wikipedia.org
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.
It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.
WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.